Sign in
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Editorial   Open access

Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?

Gavitt A Woodard, Christina Cho and Lieping Chen
Annals of surgical oncology, Vol.31(1), pp.25-27
01/2024
DOI: 10.1245/s10434-023-14388-1
PMID: 37899411
url
https://doi.org/10.1245/s10434-023-14388-1View
Published (Version of record) Open Access

Abstract

Biomarkers Immunotherapy Lymphocytes Humans Lung Neoplasms - drug therapy Neoadjuvant Therapy Prognosis T-Lymphocytes

Details

Logo image